No One Has Enough Data: Building the Federated Ecosystem for Next-Generation Drug Discovery

At this dinner you’ll

This exclusive, invitation-only Revvity Strategy Dinner in Boston brings together senior clinical leaders for an intimate, thought-provoking evening of dialogue and collaboration focused on the future of clinical oversight and data-driven decision-making. The event is designed to help you explore practical strategies for transforming how clinical data is reviewed, governed, and leveraged across increasingly complex trials.rnrn-Gain strategic insights on clinical data science — Understand how near-real-time analytics and governed review processes can elevate study performance, quality, and patient safety.rnrn-Explore AI-augmented oversight best practices — Learn how to deploy AI with guardrails that support traceability, audit-readiness, and regulatory compliance.rnrn-Benchmark against your peers — Engage in candid roundtable discussions with senior executives from the Greater Boston biotech and pharma ecosystem to compare approaches, challenges, and solutions.rnrn-Connect in a high-value setting — Build meaningful professional relationships over dinner in a relaxed, collaborative environment.rnDiscuss real business priorities — From CRO oversight maturity to organizational change management, the conversation is focused on real-world strategies that can drive measurable impact across clinical operations.rnrnWhether you’re leading data strategies, clinical operations, or innovative governance models, this dinner offers a unique opportunity to align with forward-thinking peers and spark actionable ideas for your organization’s next phase of data-driven growth.

More about Revvity

Revvity Signals Software delivers AI-powered solutions accelerating R&D and enabling data-driven innovation. Signals One, our flagship solution, streamlines R&D workflows with data capture, collaboration, data processing, and data-driven analytics. It includes i Signals Notebook, the only cloud-native electronic lab notebook with ChemDraw®, Spotfire® powered advanced analytics, as well as next-gen data management. Also new solutions include Signals BioDesign for Molecular cloning and Signals Synergy for CRO collaboration. Trusted by pharma and biotech, our portfolio empowers scientists with predictive analytics, seamless collaboration, and interactive visualizations for breakthrough discoveries. –www.revvitysignals.com